1. Adaptive single-KIR+NKG2C+ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia. Issue 11 (1st November 2022) Authors: Haroun-Izquierdo, Alvaro; Vincenti, Marianna; Netskar, Herman; van Ooijen, Hanna; Zhang, Bin; Bendzick, Laura; Kanaya, Minoru; Momayyezi, Pouria; Li, Shuo; Wiiger, Merete Thune; Hoel, Hanna Julie; Krokeide, Silje Zandstra; Kremer, Veronika; Tjonnfjord, Geir; Berggren, Stéphanie; Wikström, Kristin... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 11(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Addition of thalidomide to melphalan and prednisone treatment prolongs survival in multiple myeloma – a retrospective population based study of 1162 patients. (15th November 2013) Authors: Lund, Johan; Uttervall, Katarina; Liwing, Johan; Gahrton, Gösta; Alici, Evren; Aschan, Johan; Holmberg, Erik; Nahi, Hareth Journal: European journal of haematology Issue: Volume 92:Number 1(2014:Jan.) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Antibody response to COVID‐19 mRNA vaccine (Comirnaty) in myeloma patients treated with high‐dose melphalan and/or immunotherapy. Issue 11 (22nd September 2021) Authors: Lockmer, Sandra; Uttervall, Katarina; Kashif, Muhammad; Svärd, Carina; Malmsten, Katarina; Fletcher‐Torres, Evellyn; Alici, Evren; Lund, Johan; Nahi, Hareth Journal: American journal of hematology Issue: Volume 96:Issue 11(2021) Page Start: E443 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Case Report: Treatment of light‐chain amyloidosis with daratumumab monotherapy in two patients. (1st January 2018) Authors: Gran, Charlotte; Gahrton, Gösta; Alici, Evren; Nahi, Hareth Journal: European journal of haematology Issue: Volume 100:Number 4(2018) Page Start: 386 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Comparative evaluation of involved free light chain and monoclonal spike as markers for progression from monoclonal gammopathy of undetermined significance to multiple myeloma. Issue 1 (29th September 2020) Authors: Gran, Charlotte; Liwing, Johan; Wagner, Arnika Kathleen; Verhoek, Andre; Gezin, Ana; Alici, Evren; Nahi, Hareth Journal: American journal of hematology Issue: Volume 96:Issue 1(2021) Page Start: 23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dynamic follow‐up of smoldering multiple myeloma identifies a subset of patients at high risk of progression. Issue 3 (19th December 2020) Authors: Gran, Charlotte; Luong, Vincent; Bruchfeld, Johanna B.; Liwing, Johan; Afram, Gabriel; Lund, Johan; Usmani, Saad; Alici, Evren; Nahi, Hareth Journal: American journal of hematology Issue: Volume 96:Issue 3(2021) Page Start: E63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impact of performance status on overall survival in patients with relapsed and/or refractory multiple myeloma: Real‐life outcomes of daratumumab treatment. (29th May 2020) Authors: Afram, Garbriel; Gran, Charlotte; Borg Bruchfeld, Johanna; Wagner, Arnika Kathleen; Hussain, Alamdar; Alici, Evren; Nahi, Hareth Journal: European journal of haematology Issue: Volume 105:Number 2(2020) Page Start: 196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Improved survival in multiple Myeloma patients undergoing autologous stem cell transplantation is entirely in the standard cytogenetic risk groups. (2nd February 2021) Authors: Afram, Gabriel; Susek, Katharina Helene; Uttervall, Katarina; Wersäll, Johanna Dehlsen; Wagner, Arnika Kathleen; Luong, Vincent; Lund, Johan; Gahrton, Gösta; Alici, Evren; Nahi, Hareth Journal: European journal of haematology Issue: Volume 106:Number 4(2021) Page Start: 546 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Improved survival in myeloma patients: starting to close in on the gap between elderly patients and a matched normal population. (9th December 2013) Authors: Liwing, Johan; Uttervall, Katarina; Lund, Johan; Aldrin, Anders; Blimark, Cecilie; Carlson, Kristina; Enestig, Jon; Flogegård, Max; Forsberg, Karin; Gruber, Astrid; Haglöf Kviele, Helene; Johansson, Peter; Lauri, Birgitta; Mellqvist, Ulf‐Henrik; Swedin, Agneta; Svensson, Magnus; Näsman, Per; Alic... Journal: British journal of haematology Issue: Volume 164:Number 5(2014:Mar.) Page Start: 684 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second‐line lenalidomide + dexamethasone induction in multiple myeloma. (19th April 2018) Authors: Lund, Johan; Gruber, Astrid; Lauri, Birgitta; Duru, Adil Doganay; Blimark, Cecilie; Swedin, Agneta; Hansson, Markus; Forsberg, Karin; Ahlberg, Lucia; Carlsson, Conny; Waage, Anders; Gimsing, Peter; Vangsted, Annette Juul; Frølund, Ulf; Holmberg, Erik; Gahrton, Gösta; Alici, Evren; Hardling, Mats;... Journal: Cancer medicine Issue: Volume 7:Number 6(2018:Jun.) Page Start: 2256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗